Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors.
about
New Strategies for the Treatment of Solid Tumors with CAR-T CellsChimeric antigen receptor T-cell therapy for solid tumorsEvidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?Mesothelin-Targeted CARs: Driving T Cells to Solid TumorsCAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in LymphomaVirotherapy: cancer gene therapy at last?Trial Watch-Oncolytic viruses and cancer therapyOncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future PerspectivesVaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells.PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillanceUtilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies.Chimeric antigen receptor-redirected T cells return to the bench11R-P53 and GM-CSF Expressing Oncolytic Adenovirus Target Cancer Stem Cells with Enhanced Synergistic Activity.Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy.Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy.New immunotherapeutic strategies for the treatment of neuroblastoma.Enhancing the efficacy of adoptive cellular therapy by targeting tumor-induced immunosuppression.Antigen-specific T cell therapies for cancer.Chondroitin sulfate proteoglycan 4 as a target for chimeric antigen receptor-based T-cell immunotherapy of solid tumors.Fighting Cancer with Mathematics and Viruses.CAR T-cell immunotherapy: The path from the by-road to the freeway?Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery.Armed Oncolytic Adenovirus-Expressing PD-L1 Mini-Body Enhances Antitumor Effects of Chimeric Antigen Receptor T Cells in Solid Tumors.Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer.Current status and regulatory perspective of chimeric antigen receptor-modified T cell therapeutics.Oncolytic viruses-immunotherapeutics on the rise.Novel therapeutic strategies in human malignancy: combining immunotherapy and oncolytic virotherapy.CAR T-cell therapy of solid tumors.Dying to protect: cell death and the control of T-cell homeostasis.Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy.Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells.Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies.Adenovirotherapy Delivering Cytokine and Checkpoint Inhibitor Augments CAR T Cells against Metastatic Head and Neck Cancer.Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy.Oncolytic virus expressing RANTES and IL-15 enhances function of CAR-modified T cells in solid tumors.Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting.Prospects for combined use of oncolytic viruses and CAR T-cells.The State of Cellular Adoptive Immunotherapy for Neuroblastoma and Other Pediatric Solid Tumors.Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy.Oncolytic Virotherapy and the Tumor Microenvironment.
P2860
Q26748500-AA165DB6-B1A7-44B4-B036-BABA755E0889Q26750908-6AD23673-D971-4823-ACCE-8C19A168A07BQ26775030-A22D3F4C-3181-4358-8F9A-81AED9FC31E7Q26778759-3ACA4D6E-B54F-4D93-9C19-477FD817DED0Q26800814-2775B375-E284-45AD-846B-C236F7C9D77AQ28066228-F43C3C4B-44C1-489A-A9DB-A45DB2EE565DQ28072347-F672A3AF-F90B-4A56-A61B-D28187D7A219Q33679505-1113CD00-3427-41E6-B301-3283F19E040CQ36276185-BBD322F7-D449-40CA-917A-27008AC280BBQ36597354-503AAAFA-8AC2-4B22-A78B-9EFFC637BC4FQ37058110-55921B70-9499-4057-A2D8-C94E727BBCBEQ37301510-120D8487-BA21-46FA-A69A-94DC0392F160Q37667771-347D1410-1524-480D-A466-2270080C003FQ37718529-3C05863E-B7CF-4AFB-BDEA-EDFA6D9EE51BQ38284345-B6084D3A-0050-473C-BF2B-26F7171121B6Q38389316-6A72D54D-CDD8-4E4B-8914-70B58B46727EQ38525024-39E2540B-06F3-4DBC-8AF6-6265693736B8Q38544740-30BFA912-F861-41B0-907E-8DDE15DE0C42Q38550541-32D2BF88-BDE7-4A17-81C9-7913A608AD78Q38612646-1C2162D1-DF4C-4626-AD9F-87C82C0852BDQ38632105-F1C39C45-40F5-4B5B-861A-3480904E2BC4Q38673968-06B5B25A-6E38-4B32-97E5-D90514EC482CQ38714964-F053C4B5-A999-4D22-8263-32048C1119D5Q38719148-0C2302F2-3116-437E-B087-EA22F334B351Q38741113-D33E45DC-89E2-4A07-8776-B05136EEDFD8Q38919107-168E8C28-2517-430A-94ED-CDBDAB18CCA2Q38924557-0A8DDA47-14D3-46EB-982C-1FD7886CCE7BQ39047856-FACEAD80-7001-4218-A554-23ED6E83A3BBQ39277476-B6D69E58-ED65-4461-A41A-1679B2169F51Q39427382-CDA77C86-F231-4B28-9E1B-EAB4B222A844Q41660817-7F3C9960-753A-4BC6-988F-D362CED878A8Q41684403-0015CCE5-6BA4-4BF6-B124-D22A6D5F1EC2Q41925180-3B7350F9-352D-4C99-8034-30C837F1F13EQ41963078-F3A6F6B0-9EDA-42B4-887A-696A17258595Q42560912-29E07DCD-FE2F-4AF0-BF72-3C1E81CC6E31Q42695310-3B446DCA-DAE4-43CD-AAD9-43BED6691496Q47103891-51D774E5-9134-4551-A74B-D08A3701E79CQ47114749-1CF8F909-5CC7-4BA9-A520-0FA3F4A4521DQ47193084-8F6BCD19-1E43-40DE-957F-AAE607094CFCQ47560690-0CD980A3-98D9-4A46-884E-37EA0536CA9E
P2860
Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Armed oncolytic virus enhances ...... ified T cells in solid tumors.
@ast
Armed oncolytic virus enhances ...... ified T cells in solid tumors.
@en
Armed oncolytic virus enhances ...... ified T cells in solid tumors.
@nl
type
label
Armed oncolytic virus enhances ...... ified T cells in solid tumors.
@ast
Armed oncolytic virus enhances ...... ified T cells in solid tumors.
@en
Armed oncolytic virus enhances ...... ified T cells in solid tumors.
@nl
prefLabel
Armed oncolytic virus enhances ...... ified T cells in solid tumors.
@ast
Armed oncolytic virus enhances ...... ified T cells in solid tumors.
@en
Armed oncolytic virus enhances ...... ified T cells in solid tumors.
@nl
P2093
P2860
P1433
P1476
Armed oncolytic virus enhances ...... ified T cells in solid tumors.
@en
P2093
Barbara Savoldo
Gianpietro Dotti
Iulia Diaconu
Lisa Bouchier-Hayes
Nobuhiro Nishio
Valentina Hoyos
P2860
P304
P356
10.1158/0008-5472.CAN-14-0697
P407
P577
2014-07-24T00:00:00Z